Tamas Kozicz

Tamas Kozicz is a Professor in both Genetics and Genomic Sciences and Neuroscience at the Icahn School of Medicine at Mount Sinai in New York City. His office is located at Icahn (East) Building Floor 14 Room 75A, 1425 Madison Ave, New York, NY 10029. Dr. Kozicz maintains industry relationships with BridgeBio, providing consulting services as reported for 2024-2025.

Dr. Kozicz's research program focuses on Congenital Disorders of Glycosylation (CDG) and mitochondrial diseases, with particular emphasis on understanding neurological manifestations. His work bridges genetics, neuroscience, and metabolism through innovative approaches including organoid models, multi-omics analyses, and translational therapeutic strategies. His research spans multiple disciplines to uncover disease mechanisms and develop targeted interventions for rare genetic disorders.

Analysis of Dr. Kozicz's 2025 publications reveals a strong focus on therapeutic approaches for CDG, mitochondrial dysfunction in neurological disorders, and advanced disease modeling. His work demonstrates a comprehensive approach across genetics, neuroscience, biochemistry, and clinical medicine, with particular emphasis on viral vector therapies, interferonopathy concepts in mitochondrial disease, and multi-omics approaches to therapeutic prediction.

Dr. Kozicz has industry relationships with BridgeBio for consulting services, indicating active engagement in translating research findings into potential therapeutic applications. While specific scientific awards are not mentioned in available information, his extensive publication record in high-impact areas suggests significant recognition in his field.

Though specific details about his advising activities are not provided, Dr. Kozicz's leadership in numerous research projects suggests active mentorship of students and postdoctoral researchers. His work appears supported by substantial research funding given the complexity of studies described in his publications.

Dr. Kozicz's research likely involves collaboration with multiple laboratories at Mount Sinai focused on genetics, neuroscience, and mitochondrial medicine. His work with organoid models, multi-omics approaches, and translational therapeutics suggests a multidisciplinary research environment bridging basic science and clinical applications for rare genetic disorders.